| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Engene Therapeutics Inc. (ENGN) have been net buyers, picking up 5,102 shares worth roughly $10K on balance.
Counted by filing, the last 12 months brought 1 open-market purchase by 1 insider worth about $10K and no sales. There were none in the 12 months before that either.
The largest open-market purchase in the last two years was 5,102 shares by William Grossman (Interim Chief Medical Officer) at an average $1.97 on September 22, 2026, about $10K.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 5.1K | $8.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | William Grossman60 | Interim Chief Medical Officer | Buy | 5,102 | $1.97 | $10,050.94 | New | - | - | |
| Oct 30, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A.70 | 10% Owner | Buy | 561,797 | $8.90 | $4,999,993.30 | +22.7% | -20.2% | -19.8% | |
| Oct 8, 2024 | Forbion Growth Opportunities Fund I Cooperatief U.A.70 | 10% Owner | Buy | 470,633 | $6.40 | $3,012,673.54 | +23.5% | +5.5% | +4.4% | |
| Sep 27, 2024 | Ronald Harold Wilfred Cooper | Chief Executive Officer | Buy | 10,000 | $5.70 | $57,000.00 | New | +1.5% | +7.3% | |
| Apr 22, 2024 | De Solidarite Des Travailleurs Du Quebec Fonds78 | 10% Owner | Sell | 52,529 | $15.00 | $787,980.75 | -1.7% | -40.5% | -73.0% |